Natera stock falls to EUR 345.95 with P/ E minus 285.7

Published on 10/08/2026 at 19:32 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Natera stock costs EUR 345.95 on October 8, 2026 after EUR 353.30. Nasdaq quotes USD 388.69 versus USD 395.56, with P/E minus 285.7.

Key points in brief

Natera stock stood at EUR 345.95 at Lang & Schwarz on October 8, 2026, down 2.08 percent from EUR 353.30.
The Nasdaq quote was USD 388.69 against USD 395.56 previously, while Natera's 52-week range was USD 167.99 to USD 437.41.
Natera's market capitalization was USD 55.7 billion, with a negative P/E of 285.69 and zero dividend yield.
Natera traded below its 52-week high while Illumina and Guardant Health also declined on October 8, 2026.

NTRA, US6323071042, Illustration mit AI erstellt.

Natera stock stood at EUR 345.95 at Lang & Schwarz on October 8, 2026 at 7:30 p.m. CEST, down 2.08 percent from the EUR 353.30 prior close. The after-hours quote gives German investors a separate view of Natera's US-listed market performance.

Price sits below yearly high

The primary Nasdaq quote was USD 388.69 on October 8, 2026, versus a previous close of USD 395.56. The session price was USD 48.72 below Natera's 52-week high of USD 437.41 and USD 220.70 above its 52-week low of USD 167.99.

Trading volume reached 1,167,146 shares against an average of 1,439,470 shares. That equals 81.09 percent of the average volume, putting the session below Natera's recent trading baseline.

Valuation remains loss based

Natera had a market capitalization of USD 55.7 billion as of October 8, 2026. The trailing P/E was minus 285.69, while the dividend yield was 0.00 percent, so the valuation snapshot remains centered on market value rather than cash distributions.

Natera operates in healthcare and medical diagnostics and develops molecular testing services. Its portfolio includes reproductive health tests, Signatera cancer monitoring, and Prospera transplant monitoring, giving the company exposure to several diagnostic applications rather than one single test category.

Comparison with peers

Natera: minus 2.08 percent, P/E minus 285.69, market capitalization USD 55.7 billion

Illumina (NASDAQ, USD): minus 1.78 percent, P/E 48.83, market capitalization USD 39.8 billion

Guardant Health (NASDAQ, USD): minus 2.18 percent, P/E minus 47.15, market capitalization USD 22.1 billion

Nasdaq listing and trading frame

A master-data listing from finanzen.ch identifies Natera Inc. under ISIN US6323071042 and ticker NTRA on NASDAQ. The listing confirms the US dollar quotation used for the separate home-market figures, while the Lang & Schwarz quote remains the euro reference for this report.

Natera was trading at EUR 345.95 at Lang & Schwarz on October 8, 2026 at 7:30 p.m. CEST, minus 2.08 percent versus the EUR 353.30 prior close. The Nasdaq quote was USD 388.69 on October 8, 2026, with the US session showing a separate USD 395.56 prior close. The further course of trading is shown by the continuously updated real-time quote of Natera stock.